Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations

Clinical trial NCT05222165 · WITHDRAWN

Trial details

NCT number: NCT05222165
Sponsor: Helsinn Healthcare SA
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor CNS Tumor Recurrent WHO Grade II Glioma

Start date: 2021-10-01
Primary completion: 2022-12-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.